ALFA Finder| Management target | Revenue 25.0% FY27 |
|---|
| Revenue growth | Revenue +27.9% YoY to ₹85.4 Cr; no one-offs stated. |
|---|---|
| Margins | EBITDA 21.5% (−50bps), PAT 14.1% (−90bps) YoY; contracting. |
| Demand visibility | Management cites strong demand; declined to disclose order book. |
| Management confidence | Balanced to defensive; frequent 'we'll try' and 'not advised' hedges. |
Growth
Revenue +27.9% vs EBITDA +25.2% and PAT +20%, so profit lags sales. Nutraceuticals (₹75.3 Cr, ~88% of sales) drive growth, while margins fell (EBITDA 21.5%, −50bps; PAT 14.1%, −90bps).
Outlook
Guides 25% FY27 growth, but the new plant is only 'a couple of months' from operational. Its H2 contribution (~20%) is hedged and conditional on licensing.
Risks
Capex-heavy funding gap (₹19.9 Cr capex vs ₹7.2 Cr operating cash). Top three clients ~25–30% of revenue. Management deflected margin, order book and run-rate questions.
Earnings Call Transcript filed with NSE, NSE: INFLUX. Summary written with AI assistance from the document.
Influx Healthtech Ltd: key numbers
- Share price
- ₹251.00
- Market cap
- ₹581.1 Cr
- Revenue (annual)
- ₹146.8 Cr
- Net profit (annual)
- ₹20.54 Cr
- P/E (TTM)
- 28.3×Sector 43.0×
- Promoter holding
- 73.53%
- FII holding
- 0.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Influx Healthtech Ltd
All →Influx Healthtech Investor Presentation: Key Takeaways
H1 FY27 revenue ₹85.4cr (+27.9%), EBITDA ₹18.3cr (+25.1%, 21.5% margin), PAT ₹12.0cr (+20.0%). Capacity expansion and wellness launches drive growth.
- Call
- Guides 25% growth
Influx Healthtech H1 FY27 Results: Net Profit ₹12 Cr, Up 20.0% YoY
Influx Healthtech Ltd reported revenue from operations of ₹85.4 Cr (+27.8% YoY) and net profit of ₹12 Cr (+20.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹12 Cr · +20.0% YoY
Influx Healthtech Legal & Regulatory
NSE imposed a fine of Rs. 1.83 Lakhs on Influx Healthtech for a delay in submitting consolidated financial results for the half year ended March 31, 2026.
- Value
- ₹0.02 Cr
Influx Healthtech Annual General Meeting
Influx Healthtech Limited held its 6th Annual General Meeting on September 18, 2026. The company transacted the business items as per the AGM notice.
Influx Healthtech Other Announcement
Influx Healthtech dispatched letters to shareholders without registered emails with the FY 2025-26 Annual Report weblink and 6th AGM notice. The letters are sent under Regulation 36(1)(b) of the SEBI Listing Regulations.
Influx Healthtech Annual General Meeting
Influx Healthtech Ltd. has announced its 6th Annual General Meeting scheduled for September 18, 2026, and submitted its Annual Report for FY 2025-2026.